Table 1.
Clinical characteristics of the study women by treatment group †
| Characteristic | Thermocoagulation (n = 74) | Cryotherapy (n = 71) | P‐value |
|---|---|---|---|
| Age (years) | 31.5 ± 5.2 | 31.2 ± 5.8 | 0.738 |
| BMI | 20.37 ± 2.80 | 20.43 ± 2.61 | 0.907 |
| Pregnancy ≥1 | 56 (75.7) | 53 (74.6) | 0.886 |
| Nulliparous | 32 (43.2) | 33 (46.5) | 0.695 |
| Baseline cytology | |||
| NILM | 20 (27.0) | 19 (26.8) | 0.218 |
| ASCUS | 11 (14.9) | 19 (26.8) | |
| LSIL | 21 (28.4) | 20 (28.2) | |
| HSIL/ASC‐H | 22 (29.7) | 13 (18.3) | |
| Baseline HPV | |||
| HPV16 | 28 (37.8) | 23 (32.4) | 0.692 |
| HPV18 | 2 (2.7) | 2 (2.8) | |
| Non‐HPV16/18 | 52 (70.3) | 52 (73.2) | |
| Pathology | |||
| CIN2 | 55 (74.3) | 60 (84.5) | 0.130 |
| CIN3 | 19 (25.7) | 11 (15.5) | |
| TZ | |||
| Type I | 57 (77.0) | 47 (66.2) | 0.148 |
| Type II | 17 (23.0) | 24 (33.8) | |
†
Values are given as mean ± standard deviation or number (%).
ASC‐H, atypical squamous cells, cannot exclude HSIL; ASCUS, atypical squamous cells of undetermined significance; BMI, body mass index (calculated as weight in kilograms divided by the square of height in meters); CIN, cervical intraepithelial neoplasm; HPV, human papillomavirus; HSIL, high‐grade squamous intraepithelial lesion; LSIL, low‐grade squamous intraepithelial lesion; NILM, negative for squamous intraepithelial lesion or malignancy; TZ, transformation zone.